This study is accepting new patients by invitation only
Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias
a study on Iron Overload Sickle Cell Anemia Anemia
Summary
- Eligibility
- for people ages 3 years and up (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- ApoPharma
- ID
- NCT02443545
- Phase
- Phase 4
- Study Type
- Interventional
- Last Updated